@FiercePharma: GSK 'absorbs' reform costs in strong Q1. Story | Follow @FiercePharma
> State chapters of the National Alliance on Mental Illness received several million dollars in contributions from pharma companies in a little less than five years, with big donations from Eli Lilly, AstraZeneca and Bristol-Myers Squibb, according to a letter from Sen. Charles Grassley. Report
> The WHO has called for recall and destruction of all batches of Indian drugmaker Shantha Biotechnics' Shan5 vaccine after the discovery of "white sediment" in some vials. Report
> Shire posted better-than-expected first-quarter earnings on Thursday as new drugs offset loss of exclusivity for its blockbuster ADHD medicine Adderall XR. Release | Report
> Mylan posted a better-than-expected first-quarter profit, helped by strong overseas sales, and the generic drugmaker maintained its full-year forecast. Release | Report
> Medicines Co. posted a better-than-expected quarterly profit of $9.4 million, or 18 cents per share, helped by lower operating expense. Release | Report
> Russian drugmaker Pharmstandard says its net profit nearly doubled last year on higher sales of medicines, especially its popular Arbidol flu drug. Release | Report
> Labopharm says it was forming a joint venture with Italy's Grupo Angelini to sell the Canadian drugmaker's trazodone antidepressant in the U.S. Release | Report
> Pharmaceutical giant Pfizer has lost the sole right to manufacture Viagra in Brazil after judges decided the market for the drug should be opened up. Report
Biotech News
@FierceBiotech: E&Y: A resilient biotech industry registers its first profitable year. Article | Follow @FierceBiotech
@JohnCFierce: Pfizer developing "bio-betters," seeking rare blood disorder drugs. Article | Follow @JohnCFierce
> Novartis CEO plans to keep China R&D ops in-house. Report
> Affimed raises €20M to fund innovative antibody trials. Item
> Bill Gates bets $10M on the future of drug development software. Story
> R&D success puts Alexion at the top of the M&A list. Article
> PhDs face a tough job market as biotechs get lean and mean. Item
Vaccines News
> Novavax reports mild response in PhII seasonal flu trial. Article
> Biotechs explore promise of oncolytic immunity. Report
> CSL shares plunge on flu vax safety concerns. Story
> AFFiRiS readies Alzheimer's vax for PhII study. Item
> H1N1 vax monitoring flags potential risks. News
Manufacturing News
> FDA warns Teva (again) on propofol plant. Article
> Parenteral packaging rises to patient-compliance, brand challenges. Story
> EU okays prescription drug anticounterfeiting measures. Item
> Sebelius keeps vaccine manufacturing tech in spotlight. News
And Finally... The FDA is urging drugmakers to strengthen security practices to help prevent cargo theft. Report